Table 3:

Drugs that affected I_MI slope

Drug name	[Drug]	[Ca]	Neuromodulator	n	IMI slope (nS)
W7	0 µm	13 mm	Proctolin	12	−21.7 ± 3.7
	0.1 µm	13 mm	Proctolin	5	−13.5 ± 4.2
	1 µm	13 mm	Proctolin	6	−11.2 ± 2.4*
	10 µm	13 mm	Proctolin	6	−11.4 ± 3.9**
	100 µm	13 mm	Proctolin	6	+13.1 ± 3.4***
Calmidazolium	0 µm	13 mm	Proctolin	6	−20.4 ± 10.6
	0.1 µm	13 mm	Proctolin	2	−13.7 ± 11.1
	0.3 µm	13 mm	Proctolin	6	+1.6 ± 14
	0.0 µm	13 mm	Proctolin	4	+4.3 ± 4.9
Dantrolene	0 µm	13 mm	Proctolin	6	−8.1 ± 3.2
	3.3 µm	13 mm	Proctolin	6	+1.6 ± 1.9**
CALP1	0 µm	2 mm	Proctolin	11	+18.2 ± 4.9
	1 µm	2 mm	Proctolin	4	+10.2 ± 6.4
	10 µm	2 mm	Proctolin	4	+28.2 ± 3.8
	50 µm	2 mm	Proctolin	2	+23.5 ± 9.4
KN-93	0 µm	13 mm	Proctolin	7	−21 ± 4.2
	Low dose	13 mm	Proctolin	5	+0.8 ± 5.8
	High dose	13 mm	Proctolin	2	+16.6 ± 2.2
Pertussis toxin	0 µg/ml	13 mm	Proctolin	7	−3.1 ± 2.9
	0 µg/ml	2 mm	Proctolin	6	+14.4 ± 3.1
	10 µg/ml	13 mm	Proctolin	7	+1.5 ± 2.9
	10 µg/ml	2 mm	Proctolin	6	+21.5 ± 3.1
GTPγS	0 mm	13 mm	Proctolin	9	−2.2 ± 2.9
	0 mm	2 mm	Proctolin	8	+11.5 ± 3.1
	10 mm	13 mm	Proctolin	5	−6.7 ± 4.0
	10 mm	2 mm	Proctolin	4	+15.2 ± 4.4
Gallein	0 µm	13 mm	Proctolin	9	−5.4 ± 1.6
	1 µm	13 mm	Proctolin	9	+1.5 ± 1.9*
	3 µm	13 mm	Proctolin	9	+0.7 ± 2.8
ML-7	0 µm	13 mm	Proctolin	12	−4.2 ± 1.5
	0.1 µm	13 mm	Proctolin	12	+1.7 ± 2.3*
	1 µm	13 mm	Proctolin	10	+4.5 ± 1.4***
	10 µm	13 mm	Proctolin	7	+3.1 ± 2.4*
Dynasore, W7	0, 0 µm	13 mm	CCAP	18	−11.3 ± 1.3
	0, 33 µm	13 mm	CCAP	6	−0.4 ± 2.3***
	33, 0 µm	13 mm	CCAP	6	−12.6 ± 2.3
	33, 33 µm	13 mm	CCAP	6	−7.7 ± 2.3†
R568	0 µm	13 mm	Proctolin	10	−0.7 ± 4.5
	0 µm	2 mm	Proctolin	6	+16.5 ± 5.9
	10 µm	13 mm	Proctolin	4	+17.3 ± 7.2*
	10 µm	2 mm	Proctolin	4	+36.9 ± 7.2‡

Data are reported as the mean ± SEM. All data were obtained from LP neurons.

Tukey’s test/t test p value vs control: *p < 0.05, **p < 0.01, ***p < 0.001; †p < 0.05 vs W7 alone; ‡p < 0.05 vs low-calcium control.